Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Erratum to: Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium.

Alafuzoff I, Pikkarainen M, Neumann M, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, Ince PG, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Nilsson T, Parchi P, Patsouris E, Revesz T, Roggendorf W, Rozemuller A, Seilhean D, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H.

J Neural Transm (Vienna). 2015 Jul;122(7):973-4. doi: 10.1007/s00702-014-1337-5. No abstract available.

PMID:
25418279
2.

Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium.

Alafuzoff I, Pikkarainen M, Neumann M, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, Ince PG, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Nilsson T, Parchi P, Patsouris E, Revesz T, Roggendorf W, Rozemuller A, Seilhean D, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H.

J Neural Transm (Vienna). 2015 Jul;122(7):957-72. doi: 10.1007/s00702-014-1304-1. Epub 2014 Sep 20. Erratum in: J Neural Transm (Vienna). 2015 Jul;122(7):973-4.

3.

MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.

Gutenberg A, Bock HC, Brück W, Doerner L, Mehdorn HM, Roggendorf W, Westphal M, Felsberg J, Reifenberger G, Giese A.

Br J Neurosurg. 2013 Dec;27(6):772-8. doi: 10.3109/02688697.2013.791664. Epub 2013 May 11.

PMID:
23662801
4.

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C, Pfaff E, Tönjes M, Sill M, Bender S, Kool M, Zapatka M, Becker N, Zucknick M, Hielscher T, Liu XY, Fontebasso AM, Ryzhova M, Albrecht S, Jacob K, Wolter M, Ebinger M, Schuhmann MU, van Meter T, Frühwald MC, Hauch H, Pekrun A, Radlwimmer B, Niehues T, von Komorowski G, Dürken M, Kulozik AE, Madden J, Donson A, Foreman NK, Drissi R, Fouladi M, Scheurlen W, von Deimling A, Monoranu C, Roggendorf W, Herold-Mende C, Unterberg A, Kramm CM, Felsberg J, Hartmann C, Wiestler B, Wick W, Milde T, Witt O, Lindroth AM, Schwartzentruber J, Faury D, Fleming A, Zakrzewska M, Liberski PP, Zakrzewski K, Hauser P, Garami M, Klekner A, Bognar L, Morrissy S, Cavalli F, Taylor MD, van Sluis P, Koster J, Versteeg R, Volckmann R, Mikkelsen T, Aldape K, Reifenberger G, Collins VP, Majewski J, Korshunov A, Lichter P, Plass C, Jabado N, Pfister SM.

Cancer Cell. 2012 Oct 16;22(4):425-37. doi: 10.1016/j.ccr.2012.08.024.

5.

Dissecting the genomic complexity underlying medulloblastoma.

Jones DT, Jäger N, Kool M, Zichner T, Hutter B, Sultan M, Cho YJ, Pugh TJ, Hovestadt V, Stütz AM, Rausch T, Warnatz HJ, Ryzhova M, Bender S, Sturm D, Pleier S, Cin H, Pfaff E, Sieber L, Wittmann A, Remke M, Witt H, Hutter S, Tzaridis T, Weischenfeldt J, Raeder B, Avci M, Amstislavskiy V, Zapatka M, Weber UD, Wang Q, Lasitschka B, Bartholomae CC, Schmidt M, von Kalle C, Ast V, Lawerenz C, Eils J, Kabbe R, Benes V, van Sluis P, Koster J, Volckmann R, Shih D, Betts MJ, Russell RB, Coco S, Tonini GP, Schüller U, Hans V, Graf N, Kim YJ, Monoranu C, Roggendorf W, Unterberg A, Herold-Mende C, Milde T, Kulozik AE, von Deimling A, Witt O, Maass E, Rössler J, Ebinger M, Schuhmann MU, Frühwald MC, Hasselblatt M, Jabado N, Rutkowski S, von Bueren AO, Williamson D, Clifford SC, McCabe MG, Collins VP, Wolf S, Wiemann S, Lehrach H, Brors B, Scheurlen W, Felsberg J, Reifenberger G, Northcott PA, Taylor MD, Meyerson M, Pomeroy SL, Yaspo ML, Korbel JO, Korshunov A, Eils R, Pfister SM, Lichter P.

Nature. 2012 Aug 2;488(7409):100-5. doi: 10.1038/nature11284.

6.

The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium.

Alafuzoff I, Gelpi E, Al-Sarraj S, Arzberger T, Attems J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Englund E, Ferrer I, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, Höftberger R, Ironside JW, Jellinger K, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Rozemuller A, Seilhean D, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H.

Exp Gerontol. 2012 Nov;47(11):825-33. doi: 10.1016/j.exger.2012.06.001. Epub 2012 Jun 15.

PMID:
22705312
7.

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.

Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tönjes M, Hovestadt V, Albrecht S, Kool M, Nantel A, Konermann C, Lindroth A, Jäger N, Rausch T, Ryzhova M, Korbel JO, Hielscher T, Hauser P, Garami M, Klekner A, Bognar L, Ebinger M, Schuhmann MU, Scheurlen W, Pekrun A, Frühwald MC, Roggendorf W, Kramm C, Dürken M, Atkinson J, Lepage P, Montpetit A, Zakrzewska M, Zakrzewski K, Liberski PP, Dong Z, Siegel P, Kulozik AE, Zapatka M, Guha A, Malkin D, Felsberg J, Reifenberger G, von Deimling A, Ichimura K, Collins VP, Witt H, Milde T, Witt O, Zhang C, Castelo-Branco P, Lichter P, Faury D, Tabori U, Plass C, Majewski J, Pfister SM, Jabado N.

Nature. 2012 Jan 29;482(7384):226-31. doi: 10.1038/nature10833. Erratum in: Nature. 2012 Apr 5;484(7392):130.

PMID:
22286061
8.

Late complete remission of supratentorial primitive neuroectodermal tumor (CNS-PNET) after multiple relapses.

von Bueren AO, Warmuth-Metz M, Schlegel PG, Soerensen N, Krauss J, Roggendorf W, Pietsch T, Feiden W, Graf N, Pohl F, Flentje M, Kuehl J, Rutkowski S.

Pediatr Blood Cancer. 2011 Mar;56(3):503-5. doi: 10.1002/pbc.22914. No abstract available.

PMID:
21113945
9.

Brain tryptophan rather than pH-value is altered as consequence of artificial postmortem interval and storage conditions.

Grünblatt E, Proft F, Apfelbacher M, Deckert J, Roggendorf W, Riederer P, Monoranu CM.

Neurochem Int. 2010 Dec;57(7):819-22. doi: 10.1016/j.neuint.2010.08.020. Epub 2010 Sep 15.

PMID:
20817063
10.

Methyl- and acetyltransferases are stable epigenetic markers postmortem.

Monoranu CM, Grünblatt E, Bartl J, Meyer A, Apfelbacher M, Keller D, Michel TM, Al-Saraj S, Schmitt A, Falkai P, Roggendorf W, Deckert J, Ferrer I, Riederer P.

Cell Tissue Bank. 2011 Nov;12(4):289-97. doi: 10.1007/s10561-010-9199-z. Epub 2010 Jul 23.

PMID:
20652834
11.

Tryptophan is a marker of human postmortem brain tissue quality.

Grünblatt E, Monoranu CM, Apfelbacher M, Keller D, Michel TM, Alafuzoff I, Ferrer I, Al-Saraj S, Keyvani K, Schmitt A, Falkai P, Schittenhelm J, McLean C, Halliday GM, Harper C, Deckert J, Roggendorf W, Riederer P.

J Neurochem. 2009 Sep;110(5):1400-8. doi: 10.1111/j.1471-4159.2009.06233.x. Epub 2009 Jun 22.

12.

pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium.

Monoranu CM, Apfelbacher M, Grünblatt E, Puppe B, Alafuzoff I, Ferrer I, Al-Saraj S, Keyvani K, Schmitt A, Falkai P, Schittenhelm J, Halliday G, Kril J, Harper C, McLean C, Riederer P, Roggendorf W.

Neuropathol Appl Neurobiol. 2009 Jun;35(3):329-337. doi: 10.1111/j.1365-2990.2008.01003a.x.

13.

Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis.

Schneider D, Monoranu CM, Huang B, Rutkowski S, Gerber NU, Krauss J, Puppe B, Roggendorf W.

Cancer Genet Cytogenet. 2009 Jun;191(2):90-6. doi: 10.1016/j.cancergencyto.2009.02.010.

PMID:
19446744
14.

Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium.

Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Parchi P, Parkkinen L, Patsouris E, Roggendorf W, Rozemuller A, Stadelmann-Nessler C, Streichenberger N, Thal DR, Kretzschmar H.

Acta Neuropathol. 2009 Jun;117(6):635-52. doi: 10.1007/s00401-009-0523-2. Epub 2009 Mar 28.

PMID:
19330340
15.

Hypothalamic papillary tumor in a patient with tuberous sclerosis.

Hasselblatt M, Jozwiak J, Mayer K, Monoranu CM, Schweitzer T, Gerber NU, Krauss J, Schropp C, Bleier S, Kotulska K, Rutkowski S, Pietsch T, Sörensen N, Kersting C, Roggendorf W, Paulus W.

Am J Surg Pathol. 2008 Oct;32(10):1578-80. doi: 10.1097/PAS.0b013e318172621a.

PMID:
18724241
16.

Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium.

Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Ince P, Kamphorst W, King A, Korkolopoulou P, Kovács GG, Larionov S, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Tagliavini F, Stadelmann C, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H.

Brain Pathol. 2008 Oct;18(4):484-96. doi: 10.1111/j.1750-3639.2008.00147.x. Epub 2008 Mar 26.

17.

Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium.

Bell JE, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Budka H, Dexter DT, Falkai P, Ferrer I, Gelpi E, Gentleman SM, Giaccone G, Huitinga I, Ironside JW, Klioueva N, Kovacs GG, Meyronet D, Palkovits M, Parchi P, Patsouris E, Reynolds R, Riederer P, Roggendorf W, Seilhean D, Schmitt A, Schmitz P, Streichenberger N, Schwalber A, Kretzschmar H.

Acta Neuropathol. 2008 May;115(5):497-507. doi: 10.1007/s00401-008-0360-8. Epub 2008 Mar 26. Review.

PMID:
18365220
18.

Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortium.

Alafuzoff I, Pikkarainen M, Arzberger T, Thal DR, Al-Sarraj S, Bell J, Bodi I, Budka H, Capetillo-Zarate E, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Stadelmann C, Streichenberger N, Tagliavini F, Kretzschmar H.

Acta Neuropathol. 2008 May;115(5):533-46. doi: 10.1007/s00401-008-0358-2. Epub 2008 Mar 15.

PMID:
18343933
19.

Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas.

Monoranu CM, Huang B, Zangen IL, Rutkowski S, Vince GH, Gerber NU, Puppe B, Roggendorf W.

Cancer Genet Cytogenet. 2008 Apr 1;182(1):18-26. doi: 10.1016/j.cancergencyto.2007.12.008.

PMID:
18328946
20.

Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium.

Alafuzoff I, Parkkinen L, Al-Sarraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Kamphorst W, King A, Korkolopoulou P, Kovács GG, Larionov S, Meyronet D, Monoranu C, Morris J, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Streichenberger N, Thal DR, Kretzschmar H; BrainNet Europe Consortium.

J Neuropathol Exp Neurol. 2008 Feb;67(2):125-43. doi: 10.1097/nen.0b013e3181633526.

PMID:
18219257
21.

Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease.

Grünblatt E, Zander N, Bartl J, Jie L, Monoranu CM, Arzberger T, Ravid R, Roggendorf W, Gerlach M, Riederer P.

J Alzheimers Dis. 2007 Dec;12(4):291-311.

PMID:
18198416
22.

Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas.

Stojic J, Hagemann C, Haas S, Herbold C, Kühnel S, Gerngras S, Roggendorf W, Roosen K, Vince GH.

Neurosci Res. 2008 Jan;60(1):40-9. Epub 2007 Sep 29.

PMID:
17980449
23.

Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.

Janzarik WG, Kratz CP, Loges NT, Olbrich H, Klein C, Schäfer T, Scheurlen W, Roggendorf W, Weiller C, Niemeyer C, Korinthenberg R, Pfister S, Omran H.

Neuropediatrics. 2007 Apr;38(2):61-3.

PMID:
17712732
24.

Cytogenetic and molecular genetic analyses of giant cell glioblastoma multiforme reveal distinct profiles in giant cell and non-giant cell subpopulations.

Martinez R, Roggendorf W, Baretton G, Klein R, Toedt G, Lichter P, Schackert G, Joos S.

Cancer Genet Cytogenet. 2007 May;175(1):26-34.

PMID:
17498554
25.

Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease.

Jacob CP, Koutsilieri E, Bartl J, Neuen-Jacob E, Arzberger T, Zander N, Ravid R, Roggendorf W, Riederer P, Grünblatt E.

J Alzheimers Dis. 2007 Mar;11(1):97-116.

PMID:
17361039
26.

Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.

Lukashova-v Zangen I, Kneitz S, Monoranu CM, Rutkowski S, Hinkes B, Vince GH, Huang B, Roggendorf W.

Acta Neuropathol. 2007 Mar;113(3):325-37. Epub 2007 Jan 31.

PMID:
17265049
27.

Neuronal and ependymal expression of selenoprotein P in the human brain.

Scharpf M, Schweizer U, Arzberger T, Roggendorf W, Schomburg L, Köhrle J.

J Neural Transm (Vienna). 2007 Jul;114(7):877-84. Epub 2007 Jan 25.

PMID:
17245539
28.

Frequent but borderline methylation of p16 (INK4a) and TIMP3 in medulloblastoma and sPNET revealed by quantitative analyses.

Mühlisch J, Bajanowski T, Rickert CH, Roggendorf W, Würthwein G, Jürgens H, Frühwald MC.

J Neurooncol. 2007 May;83(1):17-29. Epub 2007 Jan 6.

PMID:
17206475
29.

How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II.

Schmitt A, Bauer M, Heinsen H, Feiden W; Consortium of Brainnet Europe II, Falkai P, Alafuzoff I, Arzberger T, Al-Sarraj S, Bell JE, Bogdanovic N, Brück W, Budka H, Ferrer I, Giaccone G, Kovacs GG, Meyronet D, Palkovits M, Parchi P, Patsouris E, Ravid R, Reynolds R, Riederer P, Roggendorf W, Schwalber A, Seilhean D, Kretzschmar H.

J Neural Transm (Vienna). 2007;114(5):527-37. Epub 2006 Dec 14.

PMID:
17165101
30.

Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).

Vordermark D, Ruprecht K, Rieckmann P, Roggendorf W, Vince GH, Warmuth-Metz M, Kölbl O, Flentje M.

BMC Cancer. 2006 Oct 18;6:247.

31.

Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium.

Alafuzoff I, Pikkarainen M, Al-Sarraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Hauw JJ, Kamphorst W, King A, Kopp N, Korkolopoulou P, Kovács GG, Meyronet D, Parchi P, Patsouris E, Preusser M, Ravid R, Roggendorf W, Seilhean D, Streichenberger N, Thal DR, Kretzschmar H.

J Neuropathol Exp Neurol. 2006 Aug;65(8):740-57.

PMID:
16896308
32.

Biological activity of paediatric cerebral cavernomas: an immunohistochemical study of 28 patients.

Tirakotai W, Fremann S, Soerensen N, Roggendorf W, Siegel AM, Mennel HD, Zhu Y, Bertalanffy H, Sure U.

Childs Nerv Syst. 2006 Jul;22(7):685-91. Epub 2006 Feb 18.

PMID:
16489474
33.

Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood.

Mühlisch J, Schwering A, Grotzer M, Vince GH, Roggendorf W, Hagemann C, Sörensen N, Rickert CH, Osada N, Jürgens H, Frühwald MC.

Oncogene. 2006 Feb 16;25(7):1111-7.

PMID:
16186793
34.

[Dementia with argyrophilic grains].

Lang CJ, Dworak O, Roggendorf W.

Fortschr Neurol Psychiatr. 2005 Sep;73(9):495-503. Review. German.

PMID:
16155860
35.

Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes.

Grünblatt E, Mandel S, Jacob-Hirsch J, Zeligson S, Amariglo N, Rechavi G, Li J, Ravid R, Roggendorf W, Riederer P, Youdim MB.

J Neural Transm (Vienna). 2004 Dec;111(12):1543-73. Epub 2004 Sep 30.

PMID:
15455214
36.

Metabolic patterns in meningiomas.

Herting B, Meixensberger J, Roggendorf W, Reichmann H.

J Neurooncol. 2003 Nov;65(2):119-23.

PMID:
14686730
37.

Human ependymomas reveal frequent deletions on chromosomes 6 and 9.

Huang B, Starostik P, Schraut H, Krauss J, Sörensen N, Roggendorf W.

Acta Neuropathol. 2003 Oct;106(4):357-62. Epub 2003 Jul 24.

PMID:
12898154
38.

Primary anaplastic large cell lymphoma of the central nervous system: prognostic effect of ALK-1 expression.

George DH, Scheithauer BW, Aker FV, Kurtin PJ, Burger PC, Cameselle-Teijeiro J, McLendon RE, Parisi JE, Paulus W, Roggendorf W, Sotelo C.

Am J Surg Pathol. 2003 Apr;27(4):487-93. Review.

PMID:
12657933
39.

Neuroleptic malignant syndrome in Kufs' disease.

Reif A, Schneider MF, Hoyer A, Schneider-Gold C, Fallgatter AJ, Roggendorf W, Pfuhlmann B.

J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):385-7.

40.

[Rhabdoid meningioma. A new malignant subtype].

Klein R, Bendszus M, Perez J, Roggendorf W.

Pathologe. 2002 Jul;23(4):297-302. German.

PMID:
12185783
41.

Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury.

Berg D, Roggendorf W, Schröder U, Klein R, Tatschner T, Benz P, Tucha O, Preier M, Lange KW, Reiners K, Gerlach M, Becker G.

Arch Neurol. 2002 Jun;59(6):999-1005.

PMID:
12056937
42.

Expression of foetal type acetylcholine receptor is restricted to type 1 muscle fibres in human neuromuscular disorders.

Gattenlöhner S, Schneider C, Thamer C, Klein R, Roggendorf W, Gohlke F, Niethammer C, Czub S, Vincent A, Müller-Hermelink HK, Marx A.

Brain. 2002 Jun;125(Pt 6):1309-19.

PMID:
12023319
43.

Loss of heterozygosity on chromosome 22 in human ependymomas.

Huang B, Starostik P, Kühl J, Tonn JC, Roggendorf W.

Acta Neuropathol. 2002 Apr;103(4):415-20. Epub 2002 Jan 17.

PMID:
11904762
44.

TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme.

Kraus JA, Wenghoefer M, Glesmann N, Mohr S, Beck M, Schmidt MC, Schröder R, Berweiler U, Roggendorf W, Diete S, Dietzmann K, Heuser K, Müller B, Fimmers R, von Deimling A, Schlegel U.

J Neurooncol. 2001 May;52(3):263-72.

PMID:
11519857
45.
46.

Long-term survival of glioblastoma multiforme: importance of histopathological reevaluation.

Kraus JA, Wenghoefer M, Schmidt MC, von Deimling A, Berweiler U, Roggendorf W, Diete S, Dietzmann K, Müller B, Heuser K, Reifenberger G, Schlegel U.

J Neurol. 2000 Jun;247(6):455-60.

PMID:
10929275
47.

[Are morphologic changes in skeletal muscles of patients with malignant hyperthermia diagnostically useful?].

Anetseder M, Pohl F, Klein R, Müller R, Hoyer A, Horbaschek H, Roggendorf W, Hartung E, Roewer N.

Anasthesiol Intensivmed Notfallmed Schmerzther. 1999 Oct;34(10):626-33. German.

PMID:
10548959
48.

Microglial/macrophage expression of interleukin 10 in human glioblastomas.

Wagner S, Czub S, Greif M, Vince GH, Süss N, Kerkau S, Rieckmann P, Roggendorf W, Roosen K, Tonn JC.

Int J Cancer. 1999 Jul 2;82(1):12-6.

49.

Primary intracerebral Hodgkin's disease: report of a case with Epstein-Barr virus association and review of the literature.

Klein R, Müllges W, Bendszus M, Woydt M, Kreipe H, Roggendorf W.

Am J Surg Pathol. 1999 Apr;23(4):477-81. Review.

PMID:
10199479
50.

Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10.

Wagner S, Stegen C, Bouterfa H, Huettner C, Kerkau S, Roggendorf W, Roosen K, Tonn JC.

J Neurooncol. 1998 Nov;40(2):113-22.

PMID:
9892093

Supplemental Content

Loading ...
Support Center